Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SNCY
|
John Gyurci
Chief Acct. Off. & VP, Finance |
SELL
Open market or private sale
|
Direct | 164 Reduced 1.39% |
$2,804
$17.1 p/Share
|
Jan 31
2025 |
|
CRDO
|
Sutardja, Pantas
Director |
SELL
Open market or private sale
|
Direct | 1,875 Reduced 0.03% |
$125,549
$66.96 p/Share
|
Jan 31
2025 |
|
ZNTL
|
Luke Nathaniel Walker
Director |
BUY
Open market or private purchase
|
Direct | 14,200 Added 14.08% |
$24,992
$1.76 p/Share
|
Jan 31
2025 |
|
ZNTL
|
Julia Marie Eastland
CEO & President |
BUY
Open market or private purchase
|
Direct | 28,500 Added 50.0% |
$49,305
$1.73 p/Share
|
Jan 31
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 115,000 Added 0.0% |
$864,800
$7.52 p/Share
|
Jan 31
2025 |
|
HIMS
|
Andrew Dudum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 78.18% |
$3,522,000
$35.22 p/Share
|
Jan 31
2025 |
|
IPAXW
|
Steven Vontur
Officer |
SELL
Open market or private sale
|
Direct | 9,266 Reduced 8.59% |
$208,485
$22.5 p/Share
|
Jan 31
2025 |
|
TXO
|
Brent W. Clum
Pres, Business Opers and CFO |
SELL
Open market or private sale
|
Direct | 7,702 Reduced 1.61% |
$143,180
$18.59 p/Share
|
Jan 31
2025 |
|
TXO
|
Scott T. Agosta
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 5,775 Reduced 3.49% |
$107,357
$18.59 p/Share
|
Jan 31
2025 |
|
NOTV
|
Robert Leasure Jr.
President and CEO |
SELL
Open market or private sale
|
Direct | 22,700 Reduced 2.16% |
$94,205
$4.15 p/Share
|
Jan 31
2025 |
|
DCOM
|
Basswood Capital Management, L.L.C. |
BUY
Open market or private purchase
|
Indirect | 1,043 Added 0.0% |
$32,572
$31.23 p/Share
|
Jan 31
2025 |
|
IBKR
|
Jill Bright |
BUY
Open market or private purchase
|
Direct | 135 Added 5.17% |
$29,633
$219.51 p/Share
|
Jan 31
2025 |
|
ACRE
|
Anton Feingold
Gen. Counsel VP and Secretary |
SELL
Open market or private sale
|
Direct | 7,615 Reduced 8.86% |
$43,253
$5.68 p/Share
|
Jan 31
2025 |
|
BILL
|
Germaine Cota
SVP, FINANCE & ACCOUNTING |
SELL
Open market or private sale
|
Direct | 3,938 Reduced 57.58% |
$393,800
$100.0 p/Share
|
Jan 31
2025 |
|
AZTA
|
Ginger Zhou
SVP and General Manager, Genom |
BUY
Open market or private purchase
|
Direct | 417 Added 1.47% |
$19,131
$45.88 p/Share
|
Jan 31
2025 |
|
BILL
|
Alison Wagonfeld |
SELL
Open market or private sale
|
Direct | 979 Reduced 100.0% |
$97,900
$100.0 p/Share
|
Jan 31
2025 |
|
TCBI
|
Robert W Stallings
Director |
BUY
Open market or private purchase
|
Indirect | 6,788 Added 0.0% |
$144,584
$21.3 p/Share
|
Jan 31
2025 |
|
CGTX
|
Lisa Ricciardi
CEO & President |
BUY
Open market or private purchase
|
Indirect | 38,851 Added 0.0% |
$29,915
$0.77 p/Share
|
Jan 31
2025 |
|
NOTV
|
Jeffrey Arthur Krupp
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 2,036 Reduced 6.55% |
$9,121
$4.48 p/Share
|
Jan 31
2025 |
|
NOTV
|
John E Sagartz
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 2,118 Reduced 0.3% |
$9,488
$4.48 p/Share
|
Jan 31
2025 |
|
ACRE
|
Jeffrey Michael Gonzales
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 4,020 Reduced 7.34% |
$22,833
$5.68 p/Share
|
Jan 31
2025 |
|
NOTV
|
Beth Taylor
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,054 Reduced 1.79% |
$9,160
$4.46 p/Share
|
Jan 31
2025 |
|
ACRE
|
Bryan Patrick Donohoe
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 23,465 Reduced 9.68% |
$133,281
$5.68 p/Share
|
Jan 31
2025 |
|
PH
|
Mark T Czaja
VP & Chief Tech. & Innov. Off. |
SELL
Open market or private sale
|
Direct | 375 Reduced 10.38% |
$266,947
$711.86 p/Share
|
Jan 31
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$23,020
$11.51 p/Share
|
Jan 31
2025 |
|
SANM
|
Alan Mc Williams Reid
EVP, Global Human Resources |
SELL
Open market or private sale
|
Direct | 3,451 Reduced 8.52% |
$290,919
$84.3 p/Share
|
Jan 31
2025 |
|
SANM
|
Charlie Mason
EVP & Global Sales |
SELL
Open market or private sale
|
Direct | 12,717 Reduced 28.76% |
$1,067,083
$83.91 p/Share
|
Jan 31
2025 |
|
FRAF
|
Craig W Best
President |
BUY
Open market or private purchase
|
Direct | 7,350 Added 45.37% |
$249,312
$33.92 p/Share
|
Jan 31
2025 |
|
BUSE
|
Stephen V King
Director |
BUY
Open market or private purchase
|
Indirect | 16,427 Added 0.0% |
$402,954
$24.53 p/Share
|
Jan 31
2025 |
|
BUSE
|
Stanley J Bradshaw
Director |
BUY
Open market or private purchase
|
Direct | 5,500 Added 1.26% |
$133,265
$24.23 p/Share
|
Jan 31
2025 |
|
PNC
|
William S Demchak
CEO |
SELL
Open market or private sale
|
Direct | 1,242 Reduced 0.24% |
$251,020
$202.11 p/Share
|
Jan 31
2025 |
|
HNVR
|
Robert Golden
Director |
SELL
Open market or private sale
|
Indirect | 2,272 Reduced 0.0% |
$60,616
$26.68 p/Share
|
Jan 31
2025 |
|
MTRN
|
Shelly Marie Chadwick
Vice President, Finance & CFO |
SELL
Open market or private sale
|
Direct | 805 Reduced 5.21% |
$81,498
$101.24 p/Share
|
Jan 31
2025 |
|
URGN
|
Jason Drew Smith
General Counsel |
SELL
Open market or private sale
|
Direct | 7,379 Reduced 18.5% |
$82,202
$11.14 p/Share
|
Jan 31
2025 |
|
BYFC
|
Wayne Kent A. Bradshaw |
SELL
Open market or private sale
|
Direct | 445 Reduced 1.16% |
$3,471
$7.8 p/Share
|
Jan 31
2025 |
|
URGN
|
Mark Schoenberg
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,551 Reduced 2.97% |
$50,698
$11.14 p/Share
|
Jan 31
2025 |
|
ORI
|
Jeffrey Lange
SVPUnderwriting & Distribution |
SELL
Open market or private sale
|
Direct | 1,098 Reduced 3.07% |
$40,142
$36.56 p/Share
|
Jan 31
2025 |
|
MODV
|
Ai Catalyst Fund, LP |
BUY
Open market or private purchase
|
Direct | 187,500 Added 8.8% |
$755,625
$4.03 p/Share
|
Jan 31
2025 |
|
IMNM
|
Clay B Siegall
President and CEO |
BUY
Open market or private purchase
|
Direct | 150,000 Added 18.3% |
$1,162,500
$7.75 p/Share
|
Jan 31
2025 |
|
BBNX
|
Mike Mensinger
Chief Product Officer |
BUY
Open market or private purchase
|
Direct | 33,350 Added 36.11% |
$566,950
$17.0 p/Share
|
Jan 31
2025 |
|
BBNX
|
Mike Mensinger
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 13 Reduced 0.05% |
$221
$17.0 p/Share
|
Jan 31
2025 |
|
CLS
|
Yann L Etienvre
Chief Operations Officer |
SELL
Open market or private sale
|
Direct | 9,181 Reduced 100.0% |
$1,170,944
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Mandeep Chawla
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,483 Reduced 100.0% |
$1,209,461
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Todd C Cooper
President |
SELL
Open market or private sale
|
Direct | 9,538 Reduced 5.16% |
$1,216,476
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Alok K. Agrawal
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 1,763 Reduced 16.05% |
$224,853
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Robert Mionis
President & CEO |
SELL
Open market or private sale
|
Direct | 52,588 Reduced 9.0% |
$6,707,073
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Leila Wong
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 3,161 Reduced 18.54% |
$403,153
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Jason Phillips
President |
SELL
Open market or private sale
|
Direct | 10,851 Reduced 100.0% |
$1,383,936
$127.54 p/Share
|
Jan 31
2025 |
|
NRIX
|
Christine Ring
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 5,760 Reduced 15.04% |
$116,409
$20.21 p/Share
|
Jan 31
2025 |
|
KALV
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect | 11,754 Added 0.0% |
$104,493
$8.89 p/Share
|
Jan 31
2025 |